New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 4, 2020 - Hikma Pharmaceuticals USA launched an AB-rated generic version of Eisai’s Banzel (rufinamide) oral suspension.
Download PDF
Return to publications
